Dr. John Howard Sampson, M.D., Ph.D, M.B.A, M.H.S.c
Scientific Advisor
Dr. Sampson is a recognized leader in the surgical resection and experimental treatment of complex brain tumors. His clinical practice is focused on treating patients with both benign and malignant brain tumors, while his research laboratory is actively investigating new modalities of direct brain tumor infusion and immunotherapy. His research led to the development of a vaccine against a common mutation in brain tumors, which has been given Breakthrough Therapy Designation by the FDA after it was shown to extend survival in patients with glioblastoma multiforme (GBM), the most malignant form of brain cancer. He has authored more than 240 peer-reviewed publications in this field and has been continuously funded by the NIH since 2000.
IAG, Image Analysis Group
Our next-gen platform, R&D and service divisions together with funding mechanisms holistically address the broader issues experienced by biopharma with active and often complex clinical trial pipelines by providing an integrated approach to clinical development and strategic planning.
Image Management Platform
Real-time information, patented data analysis methodologies, flexible reporting options for all stakeholders ensure transparency of trial process and the use of the latest scientific innovation in proving efficacy of your novel treatments.
Careers
In addition to specific listed roles, we are always looking for biotech and pharma experts and enthusiasts with entrepreneurial mindset, can-do attitude and solid scientific background.